$CNO

DeToro Karen J. sold $1.4M of CNO

DeToro Karen J. (President, Worksite Division) sold 24,674 shares of CNO Financial Group, Inc. (CNO) at an average of $54.92 ($54.73–$55.12, $1.36M total) across 5 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeToro Karen J.
Published Sep 2, 2026, 8:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNO
Bearish
medium confidence
Mentioned
$CNO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNOBearishMed
01

Why it matters

The disclosed sale reduces insider ownership and could be interpreted as a lack of confidence, prompting short‑term traders to consider downside exposure.

02

Market read

First‑report insider sale of $1.35M; material for mid‑cap insurer; may influence short‑term price action.

03

What to watch

Potential tax planning or portfolio rebalancing could be driving the sale, not company fundamentals.

Relevance 5/10Novelty 8/10Timing: post‑market 2026‑09‑02

Background

Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$CNOBearishMedium confidence
Context

President Karen J. DeToro sold 24,674 shares for $1.35M via a 10b5‑1 plan, reducing her stake to 36,450 shares.

Expected impact

Possible modest downward pressure over the next few days.

Evidence & confidence

The sale size (~$1.35M) is material for a mid‑cap insurer and executed through a pre‑arranged plan, suggesting a planned reduction rather than panic, but markets often react negatively to insider disposals.

Market effects

May raise concerns for the insurance sector if other executives follow suit.

Limited to U.S. markets where CNO trades.

Low global impact.

Counterpoint

The sale is pre‑arranged under a 10b5‑1 plan, indicating no new negative information; price may remain stable.

Key entities

  • CNO Financial Group, Inc.

    U.S. insurer and financial services provider.

  • Karen J. DeToro

    President, Worksite Division at CNO.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNOMed

California Nanotechnologies Posts 28% Revenue Growth in Q1 FY2027 as Nuclear Pivot Takes Hold

California Nanotechnologies (TSXV:CNO) reported Q1 FY2027 revenue of $917,854, up 28% from $716,553 a year earlier, for the quarter ended May 31, 2026. Adjusted EBITDA loss narrowed to $129,031 from $152,707, while net loss was $449,598. The company attributes growth to customer diversification and a nuclear supply-chain pivot tied to initial SMR component purchase orders.

$CNOHighAI 9/10

CNO Financial (CNO) Q2 2026 Earnings Call Transcript

CNO Financial Group (NYSE:CNO) reported Q2 2026 operating EPS of $1.26, up 45% year over year, and net operating income of $119.5 million. Total new annualized premiums rose 7% to a record. Full-year EPS guidance was raised to $4.60 to $4.80. The company also repurchased $60 million of shares.

$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Second Quarter 2026 Results Carmel, Ind., July 30, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its second quarter 2026 financial results: • Strong execution and momentum continues; Raising 2026 operating earni